Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV003555879 | SCV004297857 | pathogenic | not provided | 2023-07-09 | criteria provided, single submitter | clinical testing | ClinVar contains an entry for this variant (Variation ID: 557). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. This variant disrupts a region of the FECH protein in which other variant(s) (p.Cys406Tyr) have been determined to be pathogenic (PMID: 10942404; Invitae). This suggests that this is a clinically significant region of the protein, and that variants that disrupt it are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic. This premature translational stop signal has been observed in individual(s) with clinical features of erythropoietic protoporphyria (PMID: 8481408, 20412370). This sequence change creates a premature translational stop signal (p.Lys379*) in the FECH gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 45 amino acid(s) of the FECH protein. This variant is present in population databases (no rsID available, gnomAD 0.007%). |
OMIM | RCV000000587 | SCV000020736 | pathogenic | Protoporphyria, erythropoietic, 1 | 1998-07-01 | no assertion criteria provided | literature only |